Literature DB >> 17668887

Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.

Paula Bonorino1, Vincent Leroy, Tania Dufeu-Duchesne, Stefania Tongiani-Dashan, Nathalie Sturm, Martine Pernollet, Eric Vivier, Jean-Pierre Zarski, Patrice N Marche, Evelyne Jouvin-Marche.   

Abstract

UNLABELLED: CD8(+) T cells represent a sizable component of the liver inflammatory infiltrate in chronic hepatitis C and are thought to contribute to immune-mediated tissue injury. Because chronic stimulation may promote the expression by CD8(+) T cells of distinct human leukocyte antigen class I-specific natural killer cell receptors (NKRs) susceptible to both inhibiting effector functions and promoting cell survival, we examined the distribution and characteristics of CD8(+) T cells with such receptors in chronic hepatitis C patients. NKR CD8(+) T cells were detectable in liver and peripheral blood from hepatitis C virus (HCV)-infected patients but were not major subsets. However, the frequency of NKG2A(+) CD8(+) in the liver and in a lesser extent in the peripheral blood was positively correlated to histological activity in HCV-infected patients. No such correlation was found with KIR(+) T cells in liver in HCV-infected patients and with the both NKR CD8(+) T cells in hepatitis B virus (HBV) infected patients. Circulating CD8(+) T cells expressing KIRs exhibited phenotypic features of memory T cells with exacerbated expression of the senescence marker CD57 in patients. NKG2A(+)CD8(+) T cells were committed T cells that appeared less differentiated than KIR(+)CD8(+) T cells. In HCV-infected patients, their content in perforin was low and similar to that observed in NKG2A(-)CD8(+) T cells; this scenario was not observed in healthy subjects and HBV-infected patients. Both NKG2A and KIRs could inhibit the response of HCV-specific CD8(+) T cells ex vivo.
CONCLUSION: These results support the concept that an accumulation in the liver parenchyma of NKR(+)CD8(+) T cells that have functional alterations could be responsible for liver lesions. They provide novel insights into the complexity of liver-infiltrating CD8(+) T cells in chronic hepatitis C and reveal that distinct subsets of antigen-experienced CD8(+) T cells are differentially sensitive to the pervasive influence of HCV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668887     DOI: 10.1002/hep.21850

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  Permanent silencing of NKG2A expression for cell-based therapeutics.

Authors:  Constança Figueiredo; Axel Seltsam; Rainer Blasczyk
Journal:  J Mol Med (Berl)       Date:  2008-11-11       Impact factor: 4.599

2.  CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.

Authors:  Niklas K Björkström; Vivien Béziat; Frank Cichocki; Lisa L Liu; Jeffrey Levine; Stella Larsson; Richard A Koup; Stephen K Anderson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2012-09-11       Impact factor: 22.113

3.  Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

Authors:  Damien Sène; Franck Levasseur; Michal Abel; Marion Lambert; Xavier Camous; Céline Hernandez; Véronique Pène; Arielle R Rosenberg; Evelyne Jouvin-Marche; Patrice N Marche; Patrice Cacoub; Sophie Caillat-Zucman
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

4.  Killer cell immunoglobulin-like receptor expression induction on neonatal CD8(+) T cells in vitro and following congenital infection with Trypanosoma cruzi.

Authors:  Emmanuel Hermann; Aurélie Berthe; Carine Truyens; Cristina Alonso-Vega; Rudy Parrado; Faustino Torrico; Yves Carlier; Véronique M Braud
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397

5.  Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection.

Authors:  Galit Alter; Suzannah Rihn; Hendrik Streeck; Nickolas Teigen; Alicja Piechocka-Trocha; Kristin Moss; Kristen Cohen; Angela Meier; Florencia Pereyra; Bruce Walker; Marcus Altfeld
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

Review 6.  Immune responses during acute and chronic infection with hepatitis C virus.

Authors:  Shigeaki Ishii; Margaret James Koziel
Journal:  Clin Immunol       Date:  2008-06-02       Impact factor: 3.969

7.  Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.

Authors:  Susanne Knapp; Usama Warshow; Doha Hegazy; Louise Brackenbury; I Neil Guha; Andrew Fowell; Ann-Margaret Little; Graeme J Alexander; William M C Rosenberg; Matthew E Cramp; Salim I Khakoo
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

8.  T cell receptor variable β gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

Authors:  S Russi; G Lauletta; G Serviddio; S Sansonno; V Conteduca; L Sansonno; V De Re; D Sansonno
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

9.  KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif.

Authors:  Arnaud D Colantonio; Benjamin N Bimber; William J Neidermyer; R Keith Reeves; Galit Alter; Marcus Altfeld; R Paul Johnson; Mary Carrington; David H O'Connor; David T Evans
Journal:  PLoS Pathog       Date:  2011-03-10       Impact factor: 6.823

Review 10.  Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation.

Authors:  Karen L Wood; Homer L Twigg; Andrea I Doseff
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.